Organisations question EC changes on drug information for patients

BMJ 2009; 338 doi: (Published 04 March 2009) Cite this as: BMJ 2009;338:b894
  1. Rory Watson
  1. 1Brussels

    Medical and consumer organisations are raising concerns about plans by the European Commission to allow drug companies to provide information on prescription only drugs directly to the public. The drug industry is also questioning how the system would work in practice.

    The initial reactions to measures that would allow drug companies to supply factual information on prescription only drugs to the public emerged last week at a conference in Brussels organised by the European Commission and the Organisation for Professionals in Regulatory Affairs.

    The draft legislation, tabled last December, …

    View Full Text

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to to receive unlimited access to all content on for 14 days.
    Sign up for a free trial